Literature DB >> 12816916

UGT1A1*28 allele and coronary heart disease: the Rotterdam Study.

Piter J Bosma1, Irene M van der Meer, Conny T Bakker, Albert Hofman, Marianne Paul-Abrahamse, Jacqueline C Witteman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12816916     DOI： 10.1373/49.7.1180

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  18 in total

1.  Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.

Authors:  Gurusamy Umamaheswaran; Dhakchinamoorthi Krishna Kumar; Dhandapani Kayathiri; Subramanian Rajan; Deepak Gopal Shewade; Steven Aibor Dkhar; Sajjanavar Manjunath; Prayaga Ushakiran; Gangadharan Reneega; Kukreti Ritushree; Chandrasekaran Adithan
Journal:  Mol Biol Rep       Date:  2012-02-09       Impact factor: 2.316

Review 2.  The role of pharmacogenetics in cancer therapeutics.

Authors:  Wei Peng Yong; Federico Innocenti; Mark J Ratain
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

3.  Genome-wide association meta-analysis for total serum bilirubin levels.

Authors:  Andrew D Johnson; Maryam Kavousi; Albert V Smith; Ming-Huei Chen; Abbas Dehghan; Thor Aspelund; Jing-Ping Lin; Cornelia M van Duijn; Tamara B Harris; L Adrienne Cupples; Andre G Uitterlinden; Lenore Launer; Albert Hofman; Fernando Rivadeneira; Bruno Stricker; Qiong Yang; Christopher J O'Donnell; Vilmundur Gudnason; Jacqueline C Witteman
Journal:  Hum Mol Genet       Date:  2009-05-04       Impact factor: 6.150

4.  Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease.

Authors:  Arno Lingenhel; Barbara Kollerits; Johannes P Schwaiger; Steven C Hunt; Richard Gress; Paul N Hopkins; Veit Schoenborn; Iris M Heid; Florian Kronenberg
Journal:  Exp Gerontol       Date:  2008-08-26       Impact factor: 4.032

5.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

6.  Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.

Authors:  Ying-Hwa Chen; Szu-Chun Hung; Der-Cherng Tarng
Journal:  Clin J Am Soc Nephrol       Date:  2011-03       Impact factor: 8.237

7.  Genetic influences on serum bilirubin in American Indians: The Strong Heart Family Study.

Authors:  Phillip E Melton; Karin Haack; Harald H Göring; Sandy Laston; Jason G Umans; Elisa T Lee; Richard R Fabsitz; Richard B Devereux; Lyle G Best; Jean W Maccluer; Laura Almasy; Shelley A Cole
Journal:  Am J Hum Biol       Date:  2011 Jan-Feb       Impact factor: 1.937

8.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

9.  Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels--the Framingham Heart Study.

Authors:  Jing-Ping Lin; Johannes P Schwaiger; L Adrienne Cupples; Christopher J O'Donnell; Gang Zheng; Veit Schoenborn; Steven C Hunt; Jungnam Joo; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-03-19       Impact factor: 5.162

Review 10.  PharmGKB summary: very important pharmacogene information for UGT1A1.

Authors:  Julia M Barbarino; Cyrine E Haidar; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.